Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups. حسب Qingqing Hao (5464070)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Percentages (%) of concentration changes in TNF-α, IL-6, and IFN-γ released by PANC-1 cells under hypoxic and normoxic conditions cultured with CD8+ T-cells CM. حسب Eiman Abdo (20642254)

الموضوعات:

Graphical presentation of % decrease for insulin from baseline at different conditions. حسب Nathan Mubiru (21627195)

HFD decreases ITM and alters metabolic homeostasis. حسب Tong Yue (6033305)

"…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …"

Shuffling identity decreases behavior trajectory uniqueness. حسب Catalin Mitelut (5587493)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

"…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …"

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Effectiveness of the proposed method to decrease chloroplast contamination. حسب Gabriela Madrid (11871401)

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Sudden change from skewed distributions. حسب Ariel Burman (20329776)

الموضوعات:

Time and spatial sensitivity to process changes. حسب Ariel Burman (20329776)

الموضوعات:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... حسب Mingee Choi (15250732)

الموضوعات:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. حسب Mingee Choi (15250732)

الموضوعات:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات:

General information of patient who diagnosis insomnia disorder (N = 518,119). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. حسب Mingee Choi (15250732)

الموضوعات: